Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (69)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by van Meurs, J. B.J.
Right arrow Articles by Uitterlinden, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Meurs, J. B.J.
Right arrow Articles by Uitterlinden, A. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2003, Vol. 12, No. 14 1745-1754
DOI: 10.1093/hmg/ddg176
© 2003 Oxford University Press

Association of 5' estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk

Joyce B.J. van Meurs1,2,*, Stephanie C.E. Schuit1,2, Angélique E.A.M. Weel1, Marjolein van der Klift2, Arjan P. Bergink1,2, Pascal P. Arp1, Edgar M. Colin1, Yue Fang1, Albert Hofman2, Cornelia M. van Duijn2, Johannes P.T.M. van Leeuwen1, Huibert A.P. Pols1,2 and André G. Uitterlinden1,2

1Department of Internal Medicine and 2Department of Epidemiology and Biostatistics, Erasmus Medical Centre, Rotterdam, The Netherlands

Received February 27, 2003; Accepted May 9, 2003

This study investigates the influence of genetic variation of the estrogen receptor alpha (ESR1) gene locus on several bone parameters in 2042 individuals of The Rotterdam Study, a prospective population-based cohort study of elderly subjects. We analysed three polymorphic sites in the 5' region of the ESR1 gene; a (TA)n-repeat in the promoter region, and molecular haplotypes of the PvuII and XbaI RFLPs in intron 1, and inferred long-range haplotypes (LRH) thereof. We observed only three of the possible four PvuII–XbaI haplotypes in our population. A comparison with other Caucasian populations showed similar haplotype frequencies, while in Asian and African populations these were different. Linkage disequilibrium (LD) analysis between the PvuII–XbaI haplotype and the (TA)n repeat showed strong LD between the two sites. Reconstruction of long range haplotypes over the entire 5' region, revealed six frequent LRH. In men, we did not observe an association between the ESR1 polymorphisms studied and bone parameters. In women, we demonstrated an allele dose effect of haplotype ‘px’ (P=0.003) and a low number of (TA)n repeats (P=0.008) with decreased lumbar spine bone mineral density (BMD) (4.8% lower BMD in women homozygous for haplotype ‘px’, representing 28% of the population, compared with homozygous non-carriers) and decreased vertebral bone area (2.3% difference between extreme genotypes; P=0.016). Most importantly, we found an increased vertebral fracture risk with evidence for an allele dose effect with an odds ratio of 2.2 (95%CI 1.3–3.5) for haplotype ‘px’, and 2.0 (1.5–3.2) for a low number of (TA)n repeats. The ESR1 genotype dependent fracture risk is largely independent of BMD and bone area. Combination of risk alleles at both loci by long-range haplotyping improved the associations slightly, but because of the strong LD between the two polymorphic sites, we were unable to determine if any particular polymorphic site is driving the associations found. We conclude that ESR1 polymorphism in the 5' (promoter) region is associated with vertebral fracture risk, lumbar spine BMD and vertebral bone area in postmenopausal women, but not in men. The molecular mechanism underlying this association needs further study.

* To whom correspondence should be addressed at: Department of Internal Medicine, Erasmus Medical Centre, PO Box 1738, 3000 DR Rotterdam, The Netherlands. Tel: +31 104087771; Fax: +31 104089461; Email: j.vanmeurs{at}erasmusmc.nl


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CLIN APPL THROMB HEMOSTHome page
A. Morandi Alessio, L. H. Siqueira, E. C. Couto de Carvalho, R. Barini, A. de Padua Mansur, N. Fenalti Hoehr, and J. M. Annichino-Bizzacchi
Estrogen Receptor Alpha and Beta Gene Polymorphisms Are Not Risk Factors for Recurrent Miscarriage in a Brazilian Population
Clinical and Applied Thrombosis/Hemostasis, April 1, 2008; 14(2): 180 - 185.
[Abstract] [PDF]

Home page
 Arch OphthalmolHome page
S. de Voogd, R. C. W. Wolfs, N. M. Jansonius, A. G. Uitterlinden, H. A. P. Pols, A. Hofman, and P. T. V. M. de Jong
Estrogen Receptors Alpha and Beta and the Risk of Open-angle Glaucoma: The Rotterdam Study
Arch Ophthalmol, January 1, 2008; 126(1): 110 - 114.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. H. McIntyre, P. W. Kantoff, M. J. Stampfer, L. A. Mucci, D. Parslow, H. Li, J. M. Gaziano, M. Abe, and J. Ma
Prostate Cancer Risk and ESR1 TA, ESR2 CA Repeat Polymorphisms
Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2233 - 2236.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Stolk, J. B. J. van Meurs, M. Jhamai, P. P. Arp, J. P. T. van Leeuwen, A. Hofman, F. H. de Jong, H. A. P. Pols, and A. G. Uitterlinden
The Catechol-O-Methyltransferase Met158 Low-Activity Allele and Association with Nonvertebral Fracture Risk in Elderly Men
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3206 - 3212.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Grundberg, K. Akesson, A. Kindmark, P. Gerdhem, A. Holmberg, D. Mellstrom, O. Ljunggren, E. Orwoll, H. Mallmin, C. Ohlsson, et al.
The Impact of Estradiol on Bone Mineral Density Is Modulated by the Specific Estrogen Receptor-{alpha} Cofactor Retinoblastoma-Interacting Zinc Finger Protein-1 Insertion/Deletion Polymorphism
J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2300 - 2306.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. S. Boekhoorn, J. R. Vingerling, A. G. Uitterlinden, J. B. J. Van Meurs, C. M. van Duijn, H. A. P. Pols, A. Hofman, and P. T. V. M. de Jong
Estrogen Receptor {alpha} Gene Polymorphisms Associated with Incident Aging Macula Disorder
Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1012 - 1017.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
C. Sweeney, R. K. Wolff, T. Byers, K. B. Baumgartner, A. R. Giuliano, J. S. Herrick, M. A. Murtaugh, W. S. Samowitz, and M. L. Slattery
Genetic Admixture among Hispanics and Candidate Gene Polymorphisms: Potential for Confounding in a Breast Cancer Study?
Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 142 - 150.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. L. Slattery, C. Sweeney, M. Murtaugh, K. N. Ma, R. K. Wolff, J. D. Potter, B. J. Caan, and W. Samowitz
Associations between ER{alpha}, ER{beta}, and AR Genotypes and Colon and Rectal Cancer
Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2936 - 2942.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
F. J.B. van Duijnhoven, I. D. Bezemer, P. H.M. Peeters, M. Roest, A. G. Uitterlinden, D. E. Grobbee, and C. H. van Gils
Polymorphisms in the Estrogen Receptor {alpha} Gene and Mammographic Density
Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2655 - 2660.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
A. M. Shearman, S. Demissie, L. A. Cupples, I. Peter, C. H. Schmid, J. M. Ordovas, M. E. Mendelsohn, and D. E. Housman
Tobacco smoking, estrogen receptor {alpha} gene variation and small low density lipoprotein level
Hum. Mol. Genet., August 15, 2005; 14(16): 2405 - 2413.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
S. C E Schuit, F. H de Jong, L. Stolk, W N. H Koek, J. B J van Meurs, M. W C J Schoofs, M C. Zillikens, A. Hofman, J. P T M van Leeuwen, H. A P Pols, et al.
Estrogen receptor alpha gene polymorphisms are associated with estradiol levels in postmenopausal women
Eur. J. Endocrinol., August 1, 2005; 153(2): 327 - 334.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
O M E Albagha, U Pettersson, A Stewart, F E A McGuigan, H M MacDonald, D M Reid, and S H Ralston
Association of oestrogen receptor {alpha} gene polymorphisms with postmenopausal bone loss, bone mass, and quantitative ultrasound properties of bone
J. Med. Genet., March 1, 2005; 42(3): 240 - 246.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
L. Gennari, D. Merlotti, V. De Paola, A. Calabro, L. Becherini, G. Martini, and R. Nuti
Estrogen Receptor Gene Polymorphisms and the Genetics of Osteoporosis: A HuGE Review
Am. J. Epidemiol., February 15, 2005; 161(4): 307 - 320.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
H. S. Kok, N. C. Onland-Moret, K. M. van Asselt, C. H. van Gils, Y. T. van der Schouw, D. E. Grobbee, and P. H.M. Peeters
No association of estrogen receptor {alpha} and cytochrome P450c17{alpha} polymorphisms with age at menopause in a Dutch cohort
Hum. Reprod., February 1, 2005; 20(2): 536 - 542.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
J. P. A. Ioannidis, S. H. Ralston, S. T. Bennett, M. L. Brandi, D. Grinberg, F. B. Karassa, B. Langdahl, J. B. J. van Meurs, L. Mosekilde, S. Scollen, et al.
Differential Genetic Effects of ESR1 Gene Polymorphisms on Osteoporosis Outcomes
JAMA, November 3, 2004; 292(17): 2105 - 2114.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
S. C. E. Schuit, A. G. Uitterlinden, and H. A. P. Pols
Estrogen Receptor {alpha} Polymorphisms and the Risk of Myocardial Infarction--Reply
JAMA, October 13, 2004; 292(14): 1683 - 1684.
[Full Text] [PDF]

Home page
 JAMAHome page
S. C. E. Schuit, H.-H. S. Oei, J. C. M. Witteman, C. H. Geurts van Kessel, J. B. J. van Meurs, R. L. Nijhuis, J. P. T. M. van Leeuwen, F. H. de Jong, M. C. Zillikens, A. Hofman, et al.
Estrogen Receptor {alpha} Gene Polymorphisms and Risk of Myocardial Infarction
JAMA, June 23, 2004; 291(24): 2969 - 2977.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
C. Newton-Cheh and C. J. O'Donnell
Sex Differences and Genetic Associations With Myocardial Infarction
JAMA, June 23, 2004; 291(24): 3008 - 3010.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. C. E. Schuit, J. B. J. van Meurs, A. P. Bergink, M. van der Klift, Y. Fang, G. Leusink, A. Hofman, J. P. T. M. van Leeuwen, A. G. Uitterlinden, and H. A. P. Pols
Height in Pre- and Postmenopausal Women Is Influenced by Estrogen Receptor {alpha} Gene Polymorphisms
J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 303 - 309.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
P. N. Hopkins and E. A. Brinton
Estrogen Receptor 1 Variants and Coronary Artery Disease: Shedding Light Into a Murky Pool
JAMA, November 5, 2003; 290(17): 2317 - 2319.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.